בלסטווין טבע

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

VINBLASTINE SULFATE

Pieejams no:

ABIC MARKETING LTD, ISRAEL

ATĶ kods:

L01CA01

Zāļu forma:

תמיסה להזרקה

Kompozīcija:

VINBLASTINE SULFATE 1 MG / 1 ML

Ievadīšanas:

תוך-ורידי

Receptes veids:

אין צורך במרשם

Ražojis:

PHARMACHEMIE B.V., (TEVA GROUP) ,THE NETHERLANDS

Ārstniecības grupa:

VINBLASTINE

Ārstniecības joma:

VINBLASTINE

Ārstēšanas norādes:

Vinblastine has proved effective in the treatment of the following neoplasms, either alone or in conjunction with other oncolytic drugs:Frequently Responsive Malignancies :• Generalized Hodgkin's disease (Stages III and IV, Ann Arbor modification of Rye staging system)• Non-Hodgkin's lymphoma: - Reticulum-cell sarcoma - Lymphosarcoma• Mycosis fungoides.• Neuroblastoma.• Histiocytosis X.Less Frequently Responsive Malignancies :• Choriocarcinoma resistant to other chemotherapeutic agents.• Embryonal carcinoma of the testis.• Carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy.

Autorizācija datums:

2016-08-31